PT-2020-13004 · Baxter · Baxter Prismaflex+1

Published 2020-06-29 · Updated 2020-07-14 · CVE-2020-12037

Positive Technologies (AI Summary)

CVSS v3.1

7.5

High

Base vector

AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Name of the Vulnerable Software and Affected Versions Baxter PrismaFlex all versions PrisMax versions prior to 3.x

Description The affected devices do not implement data-in-transit encryption, such as TLS/SSL, when sending treatment data to a Patient Data Management System (PDMS) or an Electronic Medical Record (EMR) system. This allows an attacker to observe sensitive data sent from the device.

Recommendations For Baxter PrismaFlex all versions: Consider configuring the device to use data-in-transit encryption, such as TLS/SSL, when sending treatment data to a PDMS or EMR system. For PrisMax versions prior to 3.x: Update to version 3.x or later, which is expected to include data-in-transit encryption, such as TLS/SSL, when sending treatment data to a PDMS or EMR system. As a temporary workaround, consider restricting access to the device's communication interface to minimize the risk of exploitation.

Fix

Cleartext Transmission of Sensitive Information

Weakness Enumeration

CWE-259

CWE-319

Related Identifiers

CVE-2020-12037

Affected Products

Baxter Prismaflex

Prismax

References · 5

• https://osv.dev/vulnerability/CVE-2020-12037 · Vendor Advisory
• https://nvd.nist.gov/vuln/detail/CVE-2020-12037 · Security Note
• https://us-cert.cisa.gov/ics/advisories/icsma-20-170-02 · Note
• https://us-cert.gov/ics/advisories/icsma-20-170-01 · Note
• https://t.me/cvenotify/4710 · Telegram Post